drugset / Trial / NCT02675868

Effects of Vasopressors on Immune Response

NCT02675868

Phase 4 Completed 40 enrolled Radboud University Medical Center
RandomizedParallel-groupTriple-blindBasic science

Summary

Noradrenaline is a catecholamine and the cornerstone treatment for the improvement of hemodynamic parameters in septic shock. Catecholamines exert profound immunomodulatory effects. Noradrenaline in vitro inhibits LPS-induced pro-inflammatory cytokine production, however, the actions on immune function in vivo have not been assessed. Furthermore, effects on the immune system of viable vasopressor alternatives for the treatment of septic patients, namely phenylephrine and vasopressin, need to be established in humans in vivo.

Timeline

Start
2016-01
Primary completion
2016-07
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.05 ug/kg Intravenous
Comparator Phenylephrine Small molecule 0.5 ug/kg Intravenous
Comparator Vasopressin Peptide 0.04 iu Intravenous

Indications

No indication recorded.